The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viracta Therapeutics Inc shares valued at $2,493 were sold by Chevallard Daniel R. on Feb 27 ’24. At $0.73 per share, Chevallard Daniel R. sold 3,405 shares. The insider’s holdings dropped to 102,306 shares worth approximately $19438.14 following the completion of this transaction.
As published in a research note from Leerink Partners on August 16, 2024, Viracta Therapeutics Inc [VIRX] has been rated down from an Outperform to a Market perform and the price target has been revised to $3 from $5. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of May 03, 2021, H.C. Wainwright has initiated its “Buy” rating for VIRX. Earlier on April 26, 2021, SVB Leerink initiated its rating. Their recommendation was “an Outperform” for VIRX stock.
Analyzing VIRX Stock Performance
During the last five days, there has been a surge of approximately 21.67%. Over the course of the year, Viracta Therapeutics Inc shares have dropped approximately -66.70%. Shares of the company reached a 52-week high of $1.3100 on 04/12/24 and a 52-week low of $0.1315 on 11/15/24. A 50-day SMA is recorded $0.1933, while a 200-day SMA reached $0.5184. Nevertheless, trading volume fell to 1.51 million shares from 0.61 million shares the previous day.
Support And Resistance Levels for Viracta Therapeutics Inc (VIRX)
According to the 24-hour chart, there is a support level at 0.1712, which, if violated, would cause prices to drop to 0.1525. In the upper region, resistance lies at 0.2024. The next price resistance is at 0.2149. RSI (Relative Strength Index) is 57.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0159, which suggests the price will decrease in the coming days. Percent R is at 19.32%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
